Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04460235` - Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma	Phase 4
Completed	`NCT02215863` - Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years	Phase 4
Completed	`NCT01521897` - Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)	N/A
Completed	`NCT00197769` - Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants	Phase 2
Completed	`NCT02888457` - Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers	N/A
Completed	`NCT01995617` - Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine	Phase 1
Completed	`NCT01425372` - Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
Completed	`NCT00594347` - Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar	Phase 3
Completed	`NCT00861380` - Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease	Phase 3
Active, not recruiting	`NCT00900978` - Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants	Phase 1/Phase 2
Completed	`NCT00814710` - Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age	Phase 3
Suspended	`NCT01308827` - Costa Rica Epidemiological Study on S. Pneumoniae	N/A
Recruiting	`NCT04078997` - An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
Recruiting	`NCT06096025` - Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections
Completed	`NCT00907777` - Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™	Phase 3
Completed	`NCT00273325` - Immunogenicity of PCV-7 Vaccine in VLBW Infants
Completed	`NCT00814489` - Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults	Phase 1
Completed	`NCT01730391` - Neisseria Meningitidis Burden of Disease Study	N/A
Completed	`NCT00197821` - Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults	Phase 2
Completed	`NCT00839254` - Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A	Phase 3

NCT number	NCT00849069
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Terminated
Phase	Phase 1
Start date	March 12, 2009
Completion date	April 7, 2009

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms